Caris Partners with IBM to Expand Molecular Profiling Analysis Capabilities | GenomeWeb

NEW YORK (GenomeWeb) – Caris Life Sciences will be using IBM's technical computing and storage technology to bolster its ability to molecularly profile cancer patients and provide information that oncologists can use to personalize care.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.